425 related articles for article (PubMed ID: 31314580)
1. Genomics-Guided Immunotherapy for Precision Medicine in Cancer.
Mukherjee S
Cancer Biother Radiopharm; 2019 Oct; 34(8):487-497. PubMed ID: 31314580
[TBL] [Abstract][Full Text] [Related]
2. Immunogenomics: using genomics to personalize cancer immunotherapy.
Siniard RC; Harada S
Virchows Arch; 2017 Aug; 471(2):209-219. PubMed ID: 28528510
[TBL] [Abstract][Full Text] [Related]
3. Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review.
Syn NL; Yong WP; Goh BC; Lee SC
Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):911-22. PubMed ID: 27249175
[TBL] [Abstract][Full Text] [Related]
4. Personalized Immuno-Oncology.
Jain KK
Med Princ Pract; 2021; 30(1):1-16. PubMed ID: 32841942
[TBL] [Abstract][Full Text] [Related]
5. Personalized Oncology Meets Immunology: The Path toward Precision Immunotherapy.
Mandal R; Chan TA
Cancer Discov; 2016 Jul; 6(7):703-13. PubMed ID: 27107038
[TBL] [Abstract][Full Text] [Related]
6. Functional genomics: paving the way for more successful cancer immunotherapy.
Ajina R; Zamalin D; Weiner LM
Brief Funct Genomics; 2019 Mar; 18(2):86-98. PubMed ID: 29762641
[TBL] [Abstract][Full Text] [Related]
7. Immunogenomics in personalized cancer treatments.
Kiyotani K; Toyoshima Y; Nakamura Y
J Hum Genet; 2021 Sep; 66(9):901-907. PubMed ID: 34193979
[TBL] [Abstract][Full Text] [Related]
8. Hypermutated tumours in the era of immunotherapy: The paradigm of personalised medicine.
Nebot-Bral L; Brandao D; Verlingue L; Rouleau E; Caron O; Despras E; El-Dakdouki Y; Champiat S; Aoufouchi S; Leary A; Marabelle A; Malka D; Chaput N; Kannouche PL
Eur J Cancer; 2017 Oct; 84():290-303. PubMed ID: 28846956
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive genomic profiling for oncological advancements by precision medicine.
Pankiw M; Brezden-Masley C; Charames GS
Med Oncol; 2023 Nov; 41(1):1. PubMed ID: 37993657
[TBL] [Abstract][Full Text] [Related]
10. Integrative omics analyses broaden treatment targets in human cancer.
Sengupta S; Sun SQ; Huang KL; Oh C; Bailey MH; Varghese R; Wyczalkowski MA; Ning J; Tripathi P; McMichael JF; Johnson KJ; Kandoth C; Welch J; Ma C; Wendl MC; Payne SH; Fenyö D; Townsend RR; Dipersio JF; Chen F; Ding L
Genome Med; 2018 Jul; 10(1):60. PubMed ID: 30053901
[TBL] [Abstract][Full Text] [Related]
11. AACR precision medicine series: Highlights of the integrating clinical genomics and cancer therapy meeting.
Maggi E; Montagna C
Mutat Res; 2015 Dec; 782():44-51. PubMed ID: 26554403
[TBL] [Abstract][Full Text] [Related]
12. Implementing precision cancer medicine in the genomic era.
Chen HZ; Bonneville R; Roychowdhury S
Semin Cancer Biol; 2019 Apr; 55():16-27. PubMed ID: 29857039
[TBL] [Abstract][Full Text] [Related]
13. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
14. Clinical tumor sequencing: opportunities and challenges for precision cancer medicine.
Damodaran S; Berger MF; Roychowdhury S
Am Soc Clin Oncol Educ Book; 2015; ():e175-82. PubMed ID: 25993170
[TBL] [Abstract][Full Text] [Related]
15. The FDA Oncology Center of Excellence and precision medicine.
Goldberg KB; Blumenthal GM; McKee AE; Pazdur R
Exp Biol Med (Maywood); 2018 Feb; 243(3):308-312. PubMed ID: 29105511
[TBL] [Abstract][Full Text] [Related]
16. Molecular tests and target therapies in oncology: recommendations from the Italian workshop.
Pinto C; Biffoni M; Popoli P; Marchetti A; Marchetti P; Martini N; Normanno N
Future Oncol; 2021 Sep; 17(26):3529-3539. PubMed ID: 34254524
[TBL] [Abstract][Full Text] [Related]
17. Precision medicine: In need of guidance and surveillance.
Lin JZ; Long JY; Wang AQ; Zheng Y; Zhao HT
World J Gastroenterol; 2017 Jul; 23(28):5045-5050. PubMed ID: 28811702
[TBL] [Abstract][Full Text] [Related]
18. Overview of precision oncology trials: challenges and opportunities.
Fountzilas E; Tsimberidou AM
Expert Rev Clin Pharmacol; 2018 Aug; 11(8):797-804. PubMed ID: 30044653
[TBL] [Abstract][Full Text] [Related]
19. Artificial intelligence and neoantigens: paving the path for precision cancer immunotherapy.
Bulashevska A; Nacsa Z; Lang F; Braun M; Machyna M; Diken M; Childs L; König R
Front Immunol; 2024; 15():1394003. PubMed ID: 38868767
[TBL] [Abstract][Full Text] [Related]
20. Next-generation sequencing of cancer genomes: lessons learned.
Corrigan AE; Taylor R; Rallis KS
Future Oncol; 2021 Nov; 17(31):4041-4044. PubMed ID: 34431364
[No Abstract] [Full Text] [Related]
[Next] [New Search]